SOTAC PHARMACEUTICALS
|
The Current P/S Ratio of SOTAC PHARMACEUTICALS is 1.41.
Share Price | ₹115.0 | May 30,2024 |
Market Cap | ₹127.7 Cr | |
Sales-TTM | ₹90.2 Cr | TTM-Consolidated Results |
Price/Sales | 1.41x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of SOTAC PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹127.7 Cr] as on May 30,2024
(/) Sales [ ₹90.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.41x ]
Thus, for SOTAC PHARMACEUTICALS , the investors are currently willing to pay '1.41 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SOTAC PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of SOTAC PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of SOTAC PHARMACEUTICALS
PS Ratio Performance Analysis for SOTAC PHARMACEUTICALS
- SOTAC PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2020 averaged 0.00x.
- SOTAC PHARMACEUTICALS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, SOTAC PHARMACEUTICALS 's p/e ratio peaked in Mar2023 at 0x.
- SOTAC PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does SOTAC PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
SOTAC PHARMACEUTICALS | 90.2 | 1.41 | 127.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 48,496.9 | 7.22 | 350,195.0 |
CIPLA LTD | 25,774.1 | 4.59 | 118,275.0 |
DR REDDYS LABORATORIES LTD | 28,011.1 | 3.50 | 98,034.1 |
ZYDUS LIFESCIENCES LTD | 19,547.4 | 5.27 | 102,998.0 |
DIVIS LABORATORIES LTD | 7,845.0 | 14.93 | 117,130.0 |
MANKIND PHARMA LTD | 10,334.8 | 8.12 | 83,883.0 |
TORRENT PHARMACEUTICALS LTD | 10,728.0 | 8.39 | 89,994.3 |
LUPIN LTD | 20,010.8 | 3.59 | 71,920.7 |
AUROBINDO PHARMA LTD | 29,001.9 | 2.42 | 70,303.8 |
ABBOTT INDIA LTD | 5,848.9 | 9.44 | 55,229.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SOTAC PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.41x |
Max industry PS | 14.93x |
Median industry PS | 5.27x |
Average industry PS | 6.26x |
You may also like the below Video Courses